Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Wai Kuen Tso"'
Publikováno v:
Asian Journal of Surgery, Vol 30, Iss 4, Pp 278-282 (2007)
Radiofrequency ablation (RFA) is a treatment option in the management of unresectable or recurrent hepatocellular carcinoma (HCC). It can be performed either through laparotomy or in a minimally invasive manner by percutaneous, laparoscopic or thorac
Externí odkaz:
https://doaj.org/article/39aedbbf38ca45bdb323e3c21d3c4b62
Autor:
Ronnie T.P. Poon, Tan To Cheung, Wan Ching Yu, Kelvin K. Ng, Sheung Tat Fan, Kenneth S. H. Chok, See Ching Chan, Helen Tung, Chung Mau Lo, Wai Kuen Tso, Ferdinand S. K. Chu
Publikováno v:
Annals of Surgery. 253:981-987
This study aims to evaluate the outcome of patients with hepatocellular carcinoma (HCC) treated by high-intensity focused ultrasound (HIFU) in a single tertiary referral center.HIFU is the latest developed local ablation technique for unresectable HC
Publikováno v:
Journal of Gastrointestinal Surgery. 12:183-191
Radiofrequency ablation (RFA) is an effective local ablation therapy for hepatocellular carcinoma (HCC) with favorable long-term outcome. There is no data on the analysis of recurrence pattern and its influence on long-term survival outcome after RFA
Publikováno v:
British Journal of Surgery. 93:1488-1494
Background The aim of the present study was to assess whether an aggressive surgical approach in the management of patients with hilar cholangiocarcinoma was associated with improved operative and survival outcomes. Methods Eighty-two patients with h
Publikováno v:
Asian Journal of Surgery, Vol 27, Iss 3, Pp 213-217 (2004)
Objectives This study evaluated conservative treatment for delayed hepatic artery thrombosis after ortho-topic liver transplantation (OLT). Methods Whole-graft OLTs ( n = 108) and live donor liver transplants (LDLTs; n = 140) were performed in 237 pa
Autor:
Albert C. W. Ting, Stephen W. K. Cheng, Kai-ming Au Yeung, Pui-wai Cheng, Wai-man Lui, Pei Ho, Wai-kuen Tso
Publikováno v:
Journal of Endovascular Therapy. 11:53-59
Publikováno v:
Journal of Gastroenterology and Hepatology. 18:616-629
The management of primary and secondary malignant liver tumors poses a great challenge to clinicians. Although surgical resection is the gold-standard treatment, most patients have unresectable malignant liver tumors. Over the past decade, various mo
Publikováno v:
Journal of Gastroenterology and Hepatology. 18:337-341
Background and Aim: Hepatocellular carcinoma (HCC) is usually associated with chronic liver diseases and liver cirrhosis, while conversely, cholangiocarcinoma (CC) usually occurs in a non-cirrhotic liver. The purpose of the present study was to evalu
Publikováno v:
British Journal of Surgery. 90:325-331
Background Transarterial chemoembolization (TACE) is widely used for unresectable hepatocellular carcinoma (HCC), but the long-term survival benefit remains unclear. Methods Pretreatment variables were analysed for factors predictive of actual 5-year
Autor:
Htut Saing, Kwok-Yung Yuen, Paul K.H. Tam, Kwong-Leung Chan, John Wong, Irene Oi-Lin Ng, Sheung Tat Fan, N.S. Tsoi, William I. Wei, Wai Kuen Tso, M.T. Chau, Chung Mau Lo
Publikováno v:
Journal of Pediatric Surgery. 37:1673-1677
Purpose: The aim of this study was to analyze the early and late results of pediatric liver transplantation, with particular reference to complications that required surgical or radiologic intervention. Methods: The records and code sheets of childre